Refine by
Radiologist Articles & Analysis
221 news found
Individual dosimetry monitoring in a hospital environment is a key component of the radiation protection system, designed to measure and control the doses of ionizing radiation received by exposed workers. This monitoring is mandatory under current regulations to limit the impact of radiation on staff health while enabling them to carry out diagnostic and treatment procedures such as X-rays and ...
RTI Group, a global leader in Quality Assurance (QA) of X-ray imaging, proudly announces a landmark year marked by exceptional financial performance, significant market expansion, and strategic innovations. The company exceeded its revenue target, achieving over 125 million SEK in 2024, representing a remarkable growth of more than 20 percent compared to the previous ...
We are proud to announce that the RTI Calibration Laboratory in Mölndal, Sweden, has officially achieved ISO 17025 accreditation for Half Value Layer (HVL) calibration. This milestone allows us to expand our services, offering customers accredited HVL calibration alongside our existing ISO 17025 accredited calibrations for Tube Voltage, Air Kerma, mA/mAs, Luminance, and ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). APEX-AV is a ...
Phase III study ARASTEP initiated in hormone-sensitive prostate cancer, in patients with high-risk biochemical recurrence (BCR) who have no evidence of metastatic disease by conventional imaging and a positive PSMA PET CT at baseline Fifth major clinical trial for androgen receptor inhibitor (ARi) darolutamide, covering prostate cancer from early to metastatic stage Bayer further expands ...
ByBayer AG
Against this background, another presentation explores available publications evaluating the real-world performance of AI applications to help radiologists and their teams with insights for their clinical practice. ...
ByBayer AG
With a sharper view of the lesion, radiologists are better able to accurately diagnose PC and decide on an optimal treatment plan. ...
“Combining our knowledge and experience with Bayer will enable us to provide solutions to deliver ongoing clinical value to radiologists and their referrers.” About AI in Radiology The overall global medical imaging AI field had sales worth more than USD 400 million in 2021. ...
ByBayer AG
The approval expands Bayer’s radiology portfolio, which includes contrast media, injectors as well as digital and artificial intelligence (AI) enabled solutions, supporting radiologists across a broad range of diseases including breast cancer. “Breast cancer is the most common cancer worldwide, impacting millions of women and their loved ones around the world,” ...
ByBayer AG
We are pleased to join forces with Blackford and their exceptional team to optimally utilize our combined expertise in healthcare technology with the aim to deliver true value to radiologists and their teams for the benefit of their patients.” Blackford, which has a presence in the United Kingdom and the United States, provides infrastructure and access to a rich clinical ...
ByBayer AG
Inspirata Inc. and FUJIFILM Corporation signed an asset purchase agreement for Fujifilm to acquire Inspirata’s Dynamyx® digital pathology technology, employees and customers, building off the proven success of the established partnership between the companies in UK and Europe. This milestone allows the Digital Pathology business to flourish with a partner who has the breadth, depth and ...
Facing a high hurdle for differentiation and with the benefit of being able to learn from the extensive experience of the interventional radiologists that perform arterial embolization procedures, Sawhney and his team decided to begin with a wish list for the ideal solution. ...
An objective response rate (ORR) of 52.4% was observed in relapsed or metastatic cervical cancer in Phase I/II TORCH-2 Study of ATG-008 (onatasertib) in combination with toripalimab, regardless of PD-L1 status Study builds on promising results of Phase II TORCH monotherapy study in HBV+ patients with unresectable hepatocellular carcinoma (HCC) which demonstrated an ORR of 16.7% in the 45 mg ...
The Arktis Radiation Detectors MODES kit is designed to detect and identify radiological threats. The system can work either deployed in vehicles or as a stand-alone static monitor. The internal processing unit manages the real-time ambient spectrum. Also, our FPG drone technology can be integrated ...
FRI SUPPORTS MOVE TO DATA-DRIVEN RESPIRATORY MEDICINE Radiologists’ interpretation of images has traditionally been something of an art. ...
ByFluidda
NEW YORK, Oct. 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, randomized, placebo-controlled clinical trials were initiated in ...
ENA-001, a New Chemical Entity (NCE) with a novel mechanism of action as an agnostic respiratory stimulant, has previously been granted Rare Pediatric Disease designation for the Treatment of AoP by the FDA, with eligibility for a priority review voucher (PRV). The compound is also being developed by Enalare for the treatment of post-operative respiratory depression and community drug overdose. ...
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Department of Defense (DoD) awarded a new contract to SIGA for the procurement of up to $10.7 million of oral TPOXX (Contract number: W911SR22C0051), of which $5.1 million of oral TPOXX is ...
Among other milestones in this remarkable year: Forming a new supervisory board whose members include internationally recognised breast radiologist Dr Rachel Brem and Allyson White, Principal at Insight Partners. ...
The additional revenue may be up to $2500 per biopsy, depending on the setting and urologist/ radiologist payment structure. Visiting urologists are paid a fixed amount for performing fusion biopsies with the Fusion Bx 2.0. ...